BackAytu BioPharma Overview

Aytu BioPharma Long Term Debt

Track Aytu BioPharma's long-term debt ($10M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$10.47M

Peer average / median

Loading

Aytu BioPharma Long Term Debt History

Loading

Aytu BioPharma vs. peers: Long Term Debt Comparison

Loading

Aytu BioPharma Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Aytu BioPharma (AYTU) FAQ

Aytu BioPharma (AYTU) currently reports a long-term debt of $10M as of March 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Aytu BioPharma's long-term debt history and peer comparisons.

Aytu BioPharma's long-term debt changed from $0 to $10M (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Aytu BioPharma reported $10M in long-term debt as of March 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $10M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Aytu BioPharma, and consider following AYTU for alerts when major investors trade the stock.

Aytu BioPharma is classified in the Healthcare sector. On long-term debt, it currently shows $10M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AYTU with unrelated industries.